About This Initiative

This educational initiative will review the complex pathophysiology and clinical presentation of patients with eosinophilic esophagitis as well as recent guideline recommendations for the treatment. Although there are currently no FDA-approved therapies for EoE, current and emerging treatments will be explained, as will the critical role pharmacists play in patient counseling, assisting with access to medications, and optimizing overall care. 

On-demand Activity

Eosinophilic esophagitis (EoE) is a rare disease that has only been distinguished from gastrointestinal reflux disease since the mid-1990s. This live virtual symposium reviews the complex pathophysiology and clinical presentation of patients with EoE, including recent guideline recommendations for the treatment of EoE. Successful treatment of EoE hinges on an interprofessional approach to care. This activity also provides an interprofessional treatment plan for a patient with EoE, highlighting the pharmacist’s role.   

View Activity

Ask the Experts On-demand Activity

Join our expert faculty for this follow-up webinar addressing questions and comments from previous activity participants.


View Activity

Engaging the Experts Podcasts

Engaging the Experts

Eosinophilic Esophagitis: The Role of Allergy Testing and Dietary Interventions 

Listen Now

Where Do We Go from Here? Discussing the Future of Eosinophilic Esophagitis Treatment

Listen Now

Expert Insight Commentaries

Expert Insight

Eosinophilic Esophagitis: The New Kid on the Block

View Expert Insight

Pediatric Eosinophilic Esophagitis: Potentially Big Concerns for Little Patients

View Expert Insight